| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07096193 Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta… |
Primary endpoint(s) modified |
| 2026-06-12 | NCT07096193 Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta… |
Enrollment increased: 107 -> 200 participants |
| 2026-06-12 | NCT07096193 Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta… |
Trial sites expanded: 15 -> 19 locations |
| 2026-06-12 | NCT07096193 Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta… |
date change Primary completion pushed: 2029-02 -> 2030-01 |
| 2026-06-12 | NCT07096193 Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta… |
date change Completion pushed: 2029-02 -> 2030-01 |
| 2026-06-11 | NCT05633654 Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's… |
Trial sites expanded: 339 -> 350 locations |
| 2026-06-10 | NCT06902519 Study of GS-0151 in Participants With Rheumatoid Arthritis |
Trial sites expanded: 32 -> 35 locations |
| 2026-06-05 | NCT06532656 Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-05 | NCT06532656 Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 |
date change Primary completion pushed: 2028-02 -> 2030-07 |
| 2026-06-05 | NCT06532656 Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 |
date change Completion pushed: 2028-08 -> 2030-12 |
| 2026-06-04 | NCT04989803 Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell… |
Trial sites expanded: 18 -> 21 locations |
| 2026-06-02 | NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer |
Enrollment reduced: 270 -> 192 participants |
| 2026-06-02 | NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer |
Trial sites reduced: 100 -> 89 locations |
| 2026-05-30 | NCT07473778 Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention |
Trial sites expanded: 10 -> 17 locations |
| 2026-05-28 | NCT06031415 Study of GS-0272 in Participants With Rheumatoid Arthritis |
Trial terminated |
| 2026-05-28 | NCT06031415 Study of GS-0272 in Participants With Rheumatoid Arthritis |
critical why stopped: null → "Study terminated due to lack of efficacy." |
| 2026-05-27 | NCT06051617 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis |
Trial sites expanded: 196 -> 199 locations |
| 2026-05-21 | NCT06801834 Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously… |
Trial sites expanded: 205 -> 210 locations |
| 2026-05-19 | NCT07546812 Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-22 | NCT07601243 Study of GS-2426 in Participants With Advanced Solid Tumors | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06337032 | A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have… | HIV-1-infection | Recruiting |
| Phase 3 | |||
| NCT07047716 | Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) | HIV Pre-exposure Prophylaxis | Recruiting |
| NCT06413498 | A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants… | Multiple Myeloma | Recruiting |
| NCT07479797 | Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants… | Relapsed or Refractory Large B-cell Lymphoma | Recruiting |
| NCT06801834 | Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously… | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Recruiting |
| NCT06051617 | Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis | Primary Biliary Cholangitis | Recruiting |
| NCT05633654 | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's… | Triple Negative Breast Cancer | Recruiting |
| NCT06486441 | Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants… | Endometrial Cancer | Active, Not Recruiting |
| NCT01651403 | Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil… | Chronic Hepatitis B | Active, Not Recruiting |
| NCT05502237 | Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT04639986 | Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer… | Metastatic Breast Cancer | Active, Not Recruiting |
| NCT04994509 | Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in… | Pre-Exposure Prophylaxis of HIV Infection | Active, Not Recruiting |
| NCT05382299 | Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients… | Triple Negative Breast Cancer | Active, Not Recruiting |
| NCT05605899 | Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line… | High-risk Large B-cell Lymphoma (LBCL) | Active, Not Recruiting |
| NCT06630286 | Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With… | HIV-1-infection | Active, Not Recruiting |
| NCT03301506 | Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) | Primary Biliary Cirrhosis | Active, Not Recruiting |
| NCT02842086 | Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide… | Pre-Exposure Prophylaxis of HIV-1 Infection | Active, Not Recruiting |
| NCT05089734 | Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT06630299 | Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in… | HIV-1-Infection | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT04150068 | Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an… | HIV-1-infection | Active, Not Recruiting |
| NCT02881320 | Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in… | HIV-1 Infection | Active, Not Recruiting |
| NCT06544733 | Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly… | HIV-1-Infection | Active, Not Recruiting |
| NCT02016924 | Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co)… | Acquired Immune Deficiency Syndrome (AIDS) | Active, Not Recruiting |
| NCT06532656 | Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 | HIV-1-infection | Active, Not Recruiting |
| Phase 2 | |||
| NCT06029972 | Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active… | Ulcerative Colitis | Recruiting |